Peter Blume Jensen Acrivon Therapeutics, Inc. (ACRV) insider trading activity

Shares Held (Direct Ownership) 2.29M

2.44% 3M change

12.65% 12M change

Total Value Held N/A

Peter Blume-Jensen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Feb 21 2025	SELL Payment of exercise price or tax liability	$110,268 $5.54 p/Share	19,904 Reduced 0.86%	2,285,781 Common Stock
Feb 14 2025	SELL Payment of exercise price or tax liability	$201,363 $5.42 p/Share	37,152 Reduced 1.59%	2,305,685 Common Stock
Nov 21 2024	SELL Payment of exercise price or tax liability	$128,220 $6.44 p/Share	19,910 Reduced 0.84%	2,342,837 Common Stock
Nov 14 2024	SELL Payment of exercise price or tax liability	$473,346 $7.92 p/Share	59,766 Reduced 2.47%	2,362,747 Common Stock
Aug 21 2024	SELL Payment of exercise price or tax liability	$731,671 $9.19 p/Share	79,616 Reduced 3.18%	2,422,513 Common Stock
Aug 14 2024	SELL Payment of exercise price or tax liability	$419,550 $7.02 p/Share	59,765 Reduced 2.33%	2,502,129 Common Stock
May 14 2024	SELL Payment of exercise price or tax liability	$459,114 $8.36 p/Share	54,918 Reduced 2.1%	2,561,894 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$142,327 $3.4 p/Share	41,861 Reduced 1.57%	2,616,812 Common Stock
Nov 14 2023	SELL Payment of exercise price or tax liability	$1,214,236 $5.08 p/Share	239,023 Reduced 8.25%	2,658,673 Common Stock
Aug 21 2023	BUY Grant, award, or other acquisition	-	493,994 Added 14.56%	2,897,696 Common Stock
May 31 2023	BUY Exercise of conversion of derivative security	$130,387 $3.88 p/Share	33,605 Added 1.38%	2,403,702 Common Stock
Nov 14 2022	BUY Grant, award, or other acquisition	-	1,498,240 Added 38.73%	2,370,097 Common Stock

Peter Blume Jensen

President and CEO

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRV shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Acrivon Therapeutics, Inc. insider buys or sells ACRV shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to Acrivon Therapeutics, Inc.

Track Activities on ACRV

Account